An exploratory study to check the effectiveness of face cleanser formulations on skin imperfections through multiple instruments and assessment by the investigator
- Registration Number
- CTRI/2018/04/013504
- Lead Sponsor
- Oreal India Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 152
1. Healthy female Indian volunteers, aged 18 â?? 45 years (both inclusive)
2. Subjects with casual sebum levels >= 80 μg/cm2 and Sebum Excretion Rate >= 50 μg/cm2
3. Subjects having atleast 5 inflammatory and no more than 15 inflammatory lesions over
the whole face, out of which atleast 2 are papules of size > 0.5 mm and evolved in last
5 days (basis the medical history)
4. Subjects having at least 10 non-inflammatory acne lesions and not more than 50 non-inflammatory acne lesions over the whole face, out of which at least 50% are open comedones (black heads)
5. Subjects with medium to dark skin color having ITA values between >= 10 and <= 41
6. Subjects having at least two Post Inflammatory Hyper pigmentation spots of size 3 mm or more
7. Subjects with adequate representation of normal and sensitive skin
8. Females with a stable hormonal status, as self-declared by subjects
9. Subject who agrees not to use any other product/treatment/soap bar/any other cleanser
on their face during the study period
10. Subject who agrees not to carry out bleaching or any other procedures including facial etc. on face during the study period
11. Subject who agrees to remove all jewellery on/around face (e.g., necklace, earrings,
nose ring), during VISIA imaging
12. Female subject with child-bearing potential willing to undergo Urine Pregnancy Test
and to use acceptable methods of contraception
13. Subjects who are able to give written informed consent and to comply with the
requirements of the study
14. Subjects who are ready to follow instructions and study restrictions during the study period
1. Known hypersensitivity to any of the study products or constituents
2. Any significant skin pathology in the test area, like rosacea, severe acne, or eczema
3. Subjects on any topical or systemic treatment that could interfere with the study
treatments/assessments (topical benzoyl peroxide and other anti-acne or anti-seborreic
products, antibiotics, corticosteroids, retinoids, anti-inflammatory drugsâ?¦) within the
last 4 weeks prior to participation in the study, and during the study
4. Subjects who are having chronic illness or had major surgery in the last year
5. Subject with any significant medical condition that would interfere with the
participation in the trial
6. Subject who are allergic or sensitive to bar cleansing products/face cleansers/
creams/lotions, artificial jewellery or anything else
7. Females in pregnancy or lactation at the beginning of the study or planned during the
study
8. Subject reported or planning to sun-bathe or to overexpose to UV-light (mountain, sports, phototherapy, tanning salon useâ?¦) for aesthetic or therapeutic reasons the month before the study start or during the study
9. Participation in any other clinical trial up to 1 month prior to screening and during the
study
10. Any topical or systemic treatment(s) such as NSAIDs, corticosteroids, retinoids,
vitamins , etc. that, in the investigatorâ??s judgement, could interfere with the study
treatments / assessments, taken 2 weeks prior to inclusion and / or planned during the
study
11. Subjects Who have started, stopped or changed their hormonal treatment(s) (including
contraceptive pill) in the previous one month prior to the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method